Frontlight ResearchEarly access
Trial site
American Heart of Poland S.A.
- 11running trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Heart failure6 trials
- Atrial fibrillation2 trials
- Coronary artery disease2 trials
- Obesity2 trials
- Stroke1 trial
- Phase
- Phase 26 trials
- Phase 36 trials
- Status
- Recruiting6 trials
- Active, not recruiting5 trials
- Suspended1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Amgen Inc.1 trial
- Anthos Therapeutics, Inc.1 trial
- AskBio Inc1 trial
- Bayer1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Obesity1 recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026